ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy

ERA Congress United Kingdom United States of America France Germany Spain Austria

View original content:https://www.prnewswire.co.uk/news-releases/era-congress-long-term-data-show-sustained-efficacy-and-safety-of-zigakibart-in-patients-with-iga-nephropathy-302470916.html